Pulmonary dysfunction is a common side effect of some pediatric cancer treatments, such as chest radiotherapy. Experts discuss current screening guidelines and comment on emerging research.
While much is still unknown, healthcare providers should give special consideration to managing pediatric oncology patients during the pandemic. In this article, pediatric hematologist/oncologist Seth Rotz, MD, discusses precautions and treatment considerations for this immunocompromised population.
With advances in pediatric cancer treatment routinely enabling long-term survival, counseling young patients and their families before treatment about infertility risk and preservation strategies is essential.
Chemotherapy with anthracyclines and radiation therapy have significantly improved survival outcomes for children with many forms of cancer. Yet the effectiveness of these treatments can come at a high cost to the heart. Pediatric oncologist Seth Rotz, MD, and cardiologist Shahnawaz Amdani, MD, discuss how they screen for and manage cardiac complications during treatment for pediatric cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
An analysis of outcomes for infant allogeneic hematopoietic transplant recipients finds mixed results, with some signs of progress but no recent survival gains in patients with malignant diagnoses.
A new study clarifies cardiac risk in radiation- and anthracycline-exposed patients.
Today, more children are surviving cancer than ever before. But now, increasing efforts are needed to detect and treat late effects as early as possible.